45
Views
1
CrossRef citations to date
0
Altmetric
Articles

Antioxidant activity of calcitriol reduces direct methamphetamine-induced mitochondrial dysfunction in isolated rat heart mitochondria

ORCID Icon, , &
Pages 1139-1147 | Received 02 Feb 2021, Accepted 05 Sep 2021, Published online: 16 Oct 2021

References

  • Abdullah, C.S., et al., 2020. Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function. Communications biology, 3 (1), 1–20.
  • Ames, B.N., 2010. Optimal micronutrients delay mitochondrial decay and age-associated diseases. Mechanisms of ageing and development, 131 (7–8), 473–479.
  • Borgmann, K., and Ghorpade, A., 2018. Methamphetamine augments concurrent astrocyte mitochondrial stress, oxidative burden, and antioxidant capacity: tipping the balance in HIV-associated neurodegeneration. Neurotoxicity research, 33 (2), 433–447.
  • Calton, E.K., Keane, K.N., and Soares, M.J., 2015. The potential regulatory role of vitamin D in the bioenergetics of inflammation. Current opinion in clinical nutrition & metabolic care, 18 (4), 367–373.
  • Cass, W.A., Smith, M.P., and Peters, L.E., 2006. Calcitriol protects against the dopamine‐and serotonin‐depleting effects of neurotoxic doses of methamphetamine. Annals of the New York academy of sciences, 1074 (1), 261–271.
  • Darke, S., Duflou, J., and Kaye, S., 2017. Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study. Drug and alcohol dependence, 179, 174–179.
  • Eserian, J.K., 2013. Vitamin D as an effective treatment approach for drug abuse and addiction. Journal of medical hypotheses and ideas, 7 (2), 35–39.
  • Fanari, Z., et al., 2015. Vitamin D deficiency plays an important role in cardiac disease and affects patient outcome: Still a myth or a fact that needs exploration? Journal of the Saudi heart association, 27 (4), 264–271.
  • Jayanthi, S., et al., 2004. Methamphetamine induces neuronal apoptosis via cross‐talks between endoplasmic reticulum and mitochondria‐dependent death cascades. FASEB journal : official publication of the federation of American societies for experimental biology, 18 (2), 238–251.
  • Kang, T.-C., 2020. Nuclear factor-erythroid 2-related factor 2 (Nrf2) and mitochondrial dynamics/mitophagy in neurological diseases. Antioxidants, 9 (7), 617.
  • Ke, C.-Y., et al., 2016. Vitamin D3 reduces tissue damage and oxidative stress caused by exhaustive exercise. International journal of medical sciences, 13 (2), 147–153.
  • Kevil, C.G., et al., 2019. Methamphetamine use and cardiovascular disease. Arteriosclerosis, thrombosis, and vascular biology, 39 (9), 1739–1746.
  • Khezri, S., et al., 2020. Calcitriol reduces adverse effects of diclofenac on mitochondrial function in isolated rat heart mitochondria. Drug research, 70 (7), 317–324.
  • Krasnova, I.N., and Cadet, J.L., 2009. Methamphetamine toxicity and messengers of death. Brain research reviews, 60 (2), 379–407.
  • Kristal, B.S., Park, B.K., and Byung, P.Y., 1996. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. Journal of biological chemistry, 271 (11), 6033–6038.
  • Lord, K.C., et al., 2010. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovascular research, 87 (1), 111–118.
  • Maeno, Y., et al., 2000. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic science international, 113 (1–3), 239–243.
  • Mashayekhi, V., et al., 2014. Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity. Naunyn-Schmiedeberg's archives of pharmacology, 387 (1), 47–58.
  • Mersa, A., et al., 2020. 1, 25‐dihydroxyvitamin D3 prevents deleterious effects of erythromycin on mitochondrial function in rat heart isolated mitochondria. Clinical and experimental pharmacology & physiology, 47 (9), 1554–1563.
  • Meyer, J.N., Hartman, J.H., and Mello, D.F., 2018. Mitochondrial toxicity. Toxicological sciences : an official journal of the society of toxicology, 162 (1), 15–23.
  • Moszczynska, A., and Callan, S.P., 2017. Molecular, behavioral, and physiological consequences of methamphetamine neurotoxicity: implications for treatment. Journal of pharmacology and experimental therapeutics, 362 (3), 474–488.
  • Mozos, I., and Marginean, O., 2015. Links between vitamin D deficiency and cardiovascular diseases. BioMed research international, 2015, 1–12. 2015.
  • Myung, S.-K., et al., 2013. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ (clinical research ed.), 346, f10.
  • Peoples, J.N., et al., 2019. Mitochondrial dysfunction and oxidative stress in heart disease. Experimental & molecular medicine, 51 (12), 1–13.
  • Potula, R., et al., 2010. Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. The journal of immunology, 185 (5), 2867–2876.
  • Schürer, S., et al., 2017. Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy. JACC: heart failure, 5 (6), 435–445.
  • Shin, E.-J., et al., 2018. Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis—A review. Neurochemical research, 43 (1), 66–78.
  • Silvagno, F., et al., 2013. Mitochondrial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line. PLoS one, 8 (1), e54716.
  • Silvagno, F., et al., 2010. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS one, 5 (1), e8670.
  • Tripkovic, L., et al., 2012. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. The American Journal of Clinical nutrition, 95 (6), 1357–1364.
  • Turdi, S., et al., 2009. Acute methamphetamine exposure inhibits cardiac contractile function. Toxicology letters, 189 (2), 152–158.
  • Voskoboinik, A., et al., 2016. Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery. Internal medicine journal, 46 (6), 723–727.
  • Westover, A.N., Nakonezny, P.A., and Haley, R.W., 2008. Acute myocardial infarction in young adults who abuse amphetamines. Drug and alcohol dependence, 96 (1–2), 49–56.
  • Wimalawansa, S.J., 2019. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology, 8 (2), 30.
  • Zadak, Z., et al., 2009. Antioxidants and vitamins in clinical conditions. Physiological research., 58 (Suppl 1), S13–S17.
  • Zhao, S.X., et al., 2018. Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy. JACC: heart failure, 6 (3), 209–218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.